Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of May 13, 2025 • 8:01 PM ET

Date/Time Source News Release
05/12/2025 04:00 PM EDT GlobeNewswire BioStem Technologies Reports Preliminary First Quarter 2025 Operating and Financial Results
05/01/2025 07:00 AM EDT GlobeNewswire BioStem to Showcase its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Spring Meeting
04/30/2025 07:00 AM EDT GlobeNewswire BioStem Technologies to Host First Quarter 2025 Financial Results Conference Call on May 12, 2025
04/21/2025 07:07 AM EDT GlobeNewswire BioStem Technologies to Present at the Centri Capital Conference
04/14/2025 04:14 PM EDT GlobeNewswire BioStem Technologies Reports Record Preliminary Fourth-Quarter Net Revenue of $102.9 Million and Preliminary Full-Year 2024 Revenue of $301.8 Million
04/08/2025 07:00 AM EDT GlobeNewswire BioStem Technologies to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on April 14, 2025
04/01/2025 04:49 PM EDT GlobeNewswire BioStem Technologies Announces Extension to File 2024 Annual Report with OTC
03/31/2025 07:00 AM EDT GlobeNewswire BioStem Announces Notice of Allowance for Two U.S. Patent Applications
03/27/2025 07:00 AM EDT GlobeNewswire BioStem Technologies to Present at the 24th Annual Needham Virtual Healthcare Conference
02/24/2025 07:00 AM EST GlobeNewswire BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Trial Demonstrating the Therapeutic Benefits of BioREtain® Technology in Treating Venous Leg Ulcers
Page

Additional News

As of May 13, 2025 • 8:01 PM ET

Date/Time Source News Release
05/13/2025 02:30 PM EDT PRISM News PRISM Mid-Day Movers: Cannabis Breakout and Lunar Momentum Power Market Gains
05/13/2025 08:45 AM EDT SeekingAlpha BioStem Technologies GAAP EPS of $0.27, revenue of $72.53M misses by $28.57M
05/12/2025 09:54 PM EDT SeekingAlpha BioStem Technologies, Inc. (BSEM) Q1 2025 Earnings Call Transcript
05/12/2025 04:12 PM EDT SeekingAlpha BioStem Technologies reports higher Q1 prelim revenue
05/12/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, May 12th, 2025
05/12/2025 05:31 AM EDT US Earnings Reports Expected earnings - BioStem Technologies Inc
05/05/2025 10:20 AM EDT SeekingAlpha These are the sectors best liked within defensive and cyclicals groups - Morgan Stanley
04/16/2025 05:31 AM EDT US Earnings Reports Expected earnings - BioStem Technologies Inc
04/14/2025 07:03 PM EDT SeekingAlpha BioStem Technologies, Inc. (BSEM) Q4 2024 Earnings Call Transcript
04/14/2025 04:17 PM EDT SeekingAlpha BioStem Technologies GAAP EPS of $0.94 beats by $0.60, revenue of $102.87M beats by $16.19M
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.